The American Rhinologic Society (ARS) adopted a COI policy that permits transparent interactions between industry and ARS and its leadership.
In so doing, ARS declined to adopt the Council of Medical Specialty Society's Code for Interaction with Companies, which it said does not permit company funding and relationships. “ARS leaders believe such an extreme policy would be harmful to patients,“ noted a statement. The new policy does not set dollar amounts or limit interactions. It requires transparency—ARS said it will list relationships on its website—and creates ground rules for these relationships to prevent influence.